Hikal Limited
Hikal Limited
Action · INE475B01022 (XBOM)
Aperçu
Pas de cours
Cours de clôture XBOM 27.10.2025: 242,00 INR
27.10.2025 09:59
Cours actuels de Hikal Limited
BourseTickerDeviseDernier échangeCoursVariation journalière
XBOM: MSE
MSE
HIKAL.BO
INR
27.10.2025 09:59
242,00 INR
-0,10 INR
-0,04 %
Flottant et Liquidité des Actions
Flottant Libre 30,88 %
Actions en Flottant 38,07 M
Actions en Circulation 123,29 M
Profil de l'entreprise pour Hikal Limited Action
Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal health, biotech, crop protection, and specialty chemicals companies in India. The company operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredient (APIs). The Crop Protection segment manufactures pesticides and herbicides, which include diuron tech, temephos tech, thiacloprid tech, clothianidin tech, dichloroaniline, N-bromosuccinimide, prothioconazole technical, trifloxystrobin technical, and BIT. It also collaborates with other companies and offer solutions in contract research, custom synthesis, and custom manufacturing of intermediates and active ingredients. In addition, the company offers human health products, such as anti-convulsant, anti-emetic, anti-histaminic, anti-depressant, anti-psychotic, anti-lipemic, hemorheologic, anti-diabetic, anti-thrombotic, anti-hypertensive, anti-inflammation, and analgesic; animal health products, such as anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone, and NSAID; and specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. It also exports its products. The company operates in the United States, Canada, Europe Union, Japan, Latin America, and internationally. Hikal Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.
Obtenez des informations actualisées de finAgent sur Hikal Limited

Données de l'entreprise

Nom Hikal Limited
Société Hikal Limited
Site web https://www.hikal.com
Marché d'origine XBOM MSE
ISIN INE475B01022
Type de titre Action
Secteur Healthcare
Industrie Drug Manufacturers - Specialty & Generic
PDG Jai Vishwanath Hiremath
Capitalisation boursière 33 Mrd.
Pays Inde
Devise INR
Employés 2,1 T
Adresse Great Eastern Chambers, 400614 Navi Mumbai
Date d'introduction en bourse 2002-07-01
Dividendes de 'Hikal Limited'
Date ex-dividende Dividende par action
02.09.2025 0,80 INR

Symboles boursiers

Nom Symbole
MSE HIKAL.BO
Autres actions
Les investisseurs qui détiennent Hikal Limited ont également les actions suivantes dans leur portefeuille :
DZ BANK IS.A1257
DZ BANK IS.A1257 Obligation
Tritium DCFC Limited
Tritium DCFC Limited Action
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025